Víctor Grifols Deu

Position: Co-CEO

Type: Executive

First appointment: 27/05/16

Last appointment: 09/10/20


Mr. Víctor Grifols Deu is the joint and several Chief Executive Officer together with Mr. Raimon Grifols Roura, since 1 January 2017. He is a member of the administration bodies of several companies within the Grifols Group and was appointed executive director in May 2016. He joined the Group in 2001 as an analyst in the Planning and Control Department. In 2008 he became the director of the Planning and Control Department and was also appointed member of the Executive Committee. He was part of the team that analysed and was responsible for the integration of the transactions of Alpha Therapeutics, Talecris Biotherapeutics and Novartis' Transfusion Diagnostic Unit following the acquisitions.

He holds a degree in Business Administration and Management from the Ramon Llull University – Sarrià Chemical Institute (IQS) and a postgraduate degree in Business Administration and Management from the Michael Smurfit Business School in Dublin.

Relation with significant shareholders: Victor Grifols Deu is a shareholder of Rodellar Amsterdam Holding, B.V. (a non-controlling shareholder, pursuant to the Spanish Securities Market Act).